LithoVue Single Use Disposable Ureteroscope
Launched by UNIVERSITY OF BRITISH COLUMBIA · Jan 25, 2018
Trial Information
Current as of May 17, 2025
Unknown status
Keywords
ClinConnect Summary
Ureteroscopy is commonly used in the treatment of kidney stones. Flexible ureteroscopes are costly to purchase and repair. Issues with flexible ureteroscopes include loss of deflection and visual performance (fiberoptic pixels) with use and the high repair costs. Reprocessing and sterilization of reusable ureteroscopes also requires staff who are specially trained and dedicated in this area. Inadequate sterilization could also lead to transmissible infections between patients. A single-use flexible digital ureteroscope has recently become commercially available (LithoVue, Boston Scientific,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients scheduled for ureteroscopy and laser lithotripsy for individual renal stones ranging in size from 5 mm to 20 mm in all intrarenal locations (If there are multiple stones present, the total stone burden in cross section should not exceed 20 mm)
- • 19 years or older and able to provide informed consent
- Exclusion Criteria:
- • patients \< 18 years
- • pregnant
- • patients with known nephrocalcinosis .
- • any other reason that in the opinion of the investigator would make the participant unsuitable for enrollment in the study.
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Columbus, Ohio, United States
Patients applied
Trial Officials
Ben H Chew, MD
Principal Investigator
University of British Columbia, Associate Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials